Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Homo sapiens | parathyroid hormone 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | paired box 8 | Starlite/ChEMBL | No references |
Homo sapiens | thyroid hormone receptor, beta | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Brugia malayi | photoreceptor-specific nuclear receptor | thyroid hormone receptor, beta | 461 aa | 414 aa | 24.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.474 | 0.474 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.0246 | 0.0489 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.104 | 0.1904 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.1724 | 0.1724 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0019 | 0.0246 | 0.0246 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0019 | 0.0246 | 0.0246 |
Echinococcus granulosus | Mitotic checkpoint protein PRCC C terminal | 0.0152 | 0.5022 | 1 |
Onchocerca volvulus | 0.0291 | 1 | 1 | |
Schistosoma mansoni | hypothetical protein | 0.0152 | 0.5022 | 0.9197 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0246 | 0.045 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0246 | 0.045 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.1724 | 0.1724 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.474 | 0.474 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.104 | 0.104 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.0246 | 0.0489 |
Schistosoma mansoni | thyroid hormone receptor | 0.0164 | 0.546 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.474 | 0.474 |
Echinococcus granulosus | GPCR family 2 | 0.0019 | 0.0246 | 0.0489 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.1724 | 0.1724 |
Loa Loa (eye worm) | pax transcription factor protein 2 | 0.0291 | 1 | 1 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.0246 | 0.045 |
Echinococcus multilocularis | thyroid hormone receptor alpha | 0.0164 | 0.546 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0246 | 0.0246 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0246 | 0.045 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.1724 | 0.1724 |
Schistosoma mansoni | thyroid hormone receptor | 0.0164 | 0.546 | 1 |
Echinococcus multilocularis | Mitotic checkpoint protein PRCC, C terminal | 0.0152 | 0.5022 | 0.9197 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0246 | 0.045 |
Echinococcus multilocularis | GPCR, family 2 | 0.0019 | 0.0246 | 0.045 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0019 | 0.0246 | 0.0246 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.104 | 0.104 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.0246 | 0.045 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
AC50 (functional) | = 8.07 uM | PubChem BioAssay. HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 1.1 um | PUBCHEM_BIOASSAY: Secondary Confirmation Assay for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2, Texas Red Fluoroprobe. (Class of assay: confirmatory) [Related pubchem assays: 1573, 1469, 1570, 1479, 1571, 1572 ] | ChEMBL. | No reference |
Potency (functional) | 1.1 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2: Probe Summary. (Class of assay: summary) [Related pubchem assays (depositor defined):AID1469, AID1479, AID1567, AID1568, AID1570, AID1571, AID1573, AID2444, AID2447, AID2448, AID2449, AID2455, AID2479, AID2487, AID2490, AID2552] | ChEMBL. | No reference |
Potency (functional) | 4.4668 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | = 5.2 um | PUBCHEM_BIOASSAY: Gene Reporter Secondary Assay for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 in a Thyroid Receptor Assay. (Class of assay: confirmatory) [Related pubchem assays: 1573, 1485, 1469, 1570, 1479, 1571, 1572 ] | ChEMBL. | No reference |
Potency (functional) | 5.6234 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | = 7.6 um | PUBCHEM_BIOASSAY: Cell Viability Secondary Assay for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2. (Class of assay: confirmatory) [Related pubchem assays: 1479, 1573, 1571, 1485, 1469, 1572, 1570 ] | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.